JP2024513048A5 - - Google Patents

Info

Publication number
JP2024513048A5
JP2024513048A5 JP2023560598A JP2023560598A JP2024513048A5 JP 2024513048 A5 JP2024513048 A5 JP 2024513048A5 JP 2023560598 A JP2023560598 A JP 2023560598A JP 2023560598 A JP2023560598 A JP 2023560598A JP 2024513048 A5 JP2024513048 A5 JP 2024513048A5
Authority
JP
Japan
Prior art keywords
lnp
lipids
approximately
molar percentage
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023560598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513048A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/022642 external-priority patent/WO2022212576A1/en
Publication of JP2024513048A publication Critical patent/JP2024513048A/ja
Publication of JP2024513048A5 publication Critical patent/JP2024513048A5/ja
Pending legal-status Critical Current

Links

JP2023560598A 2021-03-31 2022-03-30 Rnaの送達のための組成物及び方法 Pending JP2024513048A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163169118P 2021-03-31 2021-03-31
US63/169,118 2021-03-31
PCT/US2022/022642 WO2022212576A1 (en) 2021-03-31 2022-03-30 Compositions and methods for delivery of rna

Publications (2)

Publication Number Publication Date
JP2024513048A JP2024513048A (ja) 2024-03-21
JP2024513048A5 true JP2024513048A5 (cg-RX-API-DMAC10.html) 2025-04-01

Family

ID=83456716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023560598A Pending JP2024513048A (ja) 2021-03-31 2022-03-30 Rnaの送達のための組成物及び方法

Country Status (8)

Country Link
US (1) US20220347112A1 (cg-RX-API-DMAC10.html)
EP (1) EP4312942A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024513048A (cg-RX-API-DMAC10.html)
CN (1) CN117396193A (cg-RX-API-DMAC10.html)
AU (1) AU2022246851A1 (cg-RX-API-DMAC10.html)
CA (1) CA3215112A1 (cg-RX-API-DMAC10.html)
IL (1) IL307319A (cg-RX-API-DMAC10.html)
WO (1) WO2022212576A1 (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117771213A (zh) * 2023-01-10 2024-03-29 北京剂泰医药科技有限公司 脂质纳米颗粒组合物及其用途
TW202509222A (zh) * 2023-05-08 2025-03-01 美商默沙東有限責任公司 編碼諾羅病毒vp1抗原之多核苷酸及其用途
WO2025049632A1 (en) * 2023-08-29 2025-03-06 Rejuvenation Technologies Inc. Compositions and methods for broad delivery of rna to tissue
WO2025255027A1 (en) * 2024-06-03 2025-12-11 Flagship Labs 114, Inc. Lipid nanoparticles for topical delivery
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026010842A1 (en) * 2024-07-01 2026-01-08 The Trustees Of The University Of Pennsylvania Use of lipid nanoparticle mrna for tert specific cancer immunotherapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10525075B2 (en) * 2013-02-22 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Compounds, compositions, methods, and kits relating to telomere extension
IL270631B2 (en) * 2017-05-16 2024-03-01 Translate Bio Inc Treatment of cystic fibrosis by delivery of codon-optimized mrna encoding cftr
CA3094057C (en) * 2018-03-27 2025-04-08 Nof Corporation CATIONIC LIPID WITH IMPROVED INTRACELLULAR DYNAMICS
GB2600800B (en) * 2018-09-04 2023-08-16 Univ Texas Compositions and methods for organ specific delivery of nucleic acids
CA3124524A1 (en) * 2019-01-04 2020-07-09 Oncorus, Inc. Encapsulated rna polynucleotides and methods of use

Similar Documents

Publication Publication Date Title
IL307319A (en) Compositions and methods for delivery of rna
US20260125339A1 (en) Ionizable cationic lipids
JP2025084968A5 (cg-RX-API-DMAC10.html)
US12102720B2 (en) Cleavable lipids
US11547764B2 (en) Lipid nanoparticle compositions and methods for MRNA delivery
JP7586886B2 (ja) 改善されたmRNA装填脂質ナノ粒子、およびそれを作製するプロセス
US20220072152A1 (en) Composition and Methods for Treatment of Ornithine Transcarbamylase Deficiency
US10576166B2 (en) Liver specific delivery of messenger RNA
ES2971849T3 (es) Compuestos lipídicos catiónicos y composiciones de los mismos para su uso en la administración de ARN mensajero
JP2022532213A5 (cg-RX-API-DMAC10.html)
JP7744354B2 (ja) Mrna担持脂質ナノ粒子を調製する改善された方法
JP2024519715A5 (cg-RX-API-DMAC10.html)
US12564645B2 (en) Methods for treatment of methylmalonic acidemia
US20210187122A1 (en) Messenger rna therapy for the treatment of friedreich's ataxia
US20220133631A1 (en) Process of preparing ice-based lipid nanoparticles
AU2021232818A1 (en) Mrna therapy for pompe disease
US20220287966A1 (en) Stable Liquid Lipid Nanoparticle Formulations